MedPath

Intraestromal Corneal Ring in Mild Keratoconus

Not Applicable
Completed
Conditions
Eye Diseases
Ophthalmological Disorder
Cornea
Keratoconus
Interventions
Device: Intraestromal corneal ring
Registration Number
NCT03127163
Lead Sponsor
University of Sao Paulo
Brief Summary

To determine whether the implantation of an intrastromal corneal ring is an effective treatment for a homogeneous group of mild keratoconus patients.

Detailed Description

A group of 65 patients with mild keratoconus were implanted with a Ferrara ring in a single eye. Six months after surgery, the aberrations were measured and the visual function was determined using clinical indices. The aberrations, especially comatic aberration (coma), were measured independently.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
65
Inclusion Criteria
  • Investigators used the Amsler-Krumeich classification and included only patients classified as grade I or II.
Read More
Exclusion Criteria
  • Investigators excluded patients with central corneal scarring, with other eye disorders, or with previous ocular surgery. We also excluded patients with a history of herpes infection, keratitis, corneal dystrophies, diagnoses of autoimmune diseases, systemic connective tissue disorders, or acute keratoconus.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Mild KeratoconusIntraestromal corneal ringA group of 65 patients with keratoconus who were implanted with an intrastromal corneal ring; the group was composed of 40 males (61.50%) and 25 females (38.50%), with a mean age of 27.88 ± 7.38 years (range, 17-47 years). The patients were fully informed about the study and signed a consent form previously approved by the ethics committee of our institution. We used the Amsler-Krumeich classification and included only patients classified as grade I or II. The investigators performed the intraestromal corneal ring surgery in the selected group.
Primary Outcome Measures
NameTimeMethod
Aberrations were measured and the visual function was determined using clinical indices.3 months after surgery

Wave front data

Secondary Outcome Measures
NameTimeMethod
UCVA3 months after surgery

Uncorrected visual acuity

BCVA3 months after surgery

Best corrected visual acuity

Trial Locations

Locations (1)

Hospital das Clínicas

🇧🇷

Sao Paulo, SP, Brazil

© Copyright 2025. All Rights Reserved by MedPath